These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
384 related articles for article (PubMed ID: 37298496)
1. Parkinson's Disease: From Genetics and Epigenetics to Treatment, a miRNA-Based Strategy. Paccosi E; Proietti-De-Santis L Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298496 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review. Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973 [TBL] [Abstract][Full Text] [Related]
4. The role of exosomes in pathogenesis and the therapeutic efficacy of mesenchymal stem cell-derived exosomes against Parkinson's disease. Abrishamdar M; Jalali MS; Yazdanfar N Neurol Sci; 2023 Jul; 44(7):2277-2289. PubMed ID: 36949298 [TBL] [Abstract][Full Text] [Related]
5. microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches. Leggio L; Vivarelli S; L'Episcopo F; Tirolo C; Caniglia S; Testa N; Marchetti B; Iraci N Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29236052 [TBL] [Abstract][Full Text] [Related]
6. Novel insights into the role of circular RNAs in Parkinson disease: An emerging renaissance in the management of neurodegenerative diseases. Dorostgou Z; Yadegar N; Dorostgou Z; Khorvash F; Vakili O J Neurosci Res; 2022 Sep; 100(9):1775-1790. PubMed ID: 35642104 [TBL] [Abstract][Full Text] [Related]
7. The understanding of Parkinson's disease through genetics and new therapies. Uwishema O; Onyeaka H; Badri R; Yücel AN; Korkusuz AK; Ajagbe AO; Abuleil A; Chaaya C; Alhendawi BHM; Chalhoub E Brain Behav; 2022 May; 12(5):e2577. PubMed ID: 35451243 [TBL] [Abstract][Full Text] [Related]
8. Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Parkinson's disease. Mohammed OA; Elballal MS; El-Husseiny AA; Khidr EG; El Tabaa MM; Elazazy O; Abd-Elmawla MA; Elesawy AE; Ibrahim HM; Abulsoud AI; El-Dakroury WA; Abdel Mageed SS; Elrebehy MA; Nomier Y; Abdel-Reheim MA; El-Husseiny HM; Mahmoud AMA; Saber S; Doghish AS Pathol Res Pract; 2024 Jan; 253():155023. PubMed ID: 38081104 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA Dysregulation in Parkinson's Disease: A Narrative Review. Nies YH; Mohamad Najib NH; Lim WL; Kamaruzzaman MA; Yahaya MF; Teoh SL Front Neurosci; 2021; 15():660379. PubMed ID: 33994934 [TBL] [Abstract][Full Text] [Related]
10. Parkinson's disease: Autoimmunity and neuroinflammation. De Virgilio A; Greco A; Fabbrini G; Inghilleri M; Rizzo MI; Gallo A; Conte M; Rosato C; Ciniglio Appiani M; de Vincentiis M Autoimmun Rev; 2016 Oct; 15(10):1005-11. PubMed ID: 27497913 [TBL] [Abstract][Full Text] [Related]
11. Mesenchymal Stem Cells-derived Exosomes: A New Possible Therapeutic Strategy for Parkinson's Disease? Vilaça-Faria H; Salgado AJ; Teixeira FG Cells; 2019 Feb; 8(2):. PubMed ID: 30717429 [TBL] [Abstract][Full Text] [Related]
12. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model. Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254 [TBL] [Abstract][Full Text] [Related]
13. miRNA in Parkinson's disease: From pathogenesis to theranostic approaches. Elangovan A; Venkatesan D; Selvaraj P; Pasha MY; Babu HWS; Iyer M; Narayanasamy A; Subramaniam MD; Valsala Gopalakrishnan A; Kumar NS; Vellingiri B J Cell Physiol; 2023 Feb; 238(2):329-354. PubMed ID: 36502506 [TBL] [Abstract][Full Text] [Related]
14. Potential Role of Caffeine in the Treatment of Parkinson's Disease. Roshan MH; Tambo A; Pace NP Open Neurol J; 2016; 10():42-58. PubMed ID: 27563362 [TBL] [Abstract][Full Text] [Related]
15. Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives. Sarkar S; Raymick J; Imam S Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338353 [TBL] [Abstract][Full Text] [Related]
16. Cellular and Molecular Events Leading to Paraquat-Induced Apoptosis: Mechanistic Insights into Parkinson's Disease Pathophysiology. See WZC; Naidu R; Tang KS Mol Neurobiol; 2022 Jun; 59(6):3353-3369. PubMed ID: 35306641 [TBL] [Abstract][Full Text] [Related]
17. The Potential Roles of Extracellular Vesicles as Biomarkers for Parkinson's Disease: A Systematic Review. Valencia J; Ferreira M; Merino-Torres JF; Marcilla A; Soriano JM Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232833 [TBL] [Abstract][Full Text] [Related]
18. Does the Expression and Epigenetics of Genes Involved in Monogenic Forms of Parkinson's Disease Influence Sporadic Forms? Lanore A; Lesage S; Mariani LL; Menon PJ; Ravassard P; Cheval H; Corti O; Brice A; Corvol JC Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328033 [TBL] [Abstract][Full Text] [Related]
19. Initiation and propagation of α-synuclein aggregation in the nervous system. Hijaz BA; Volpicelli-Daley LA Mol Neurodegener; 2020 Mar; 15(1):19. PubMed ID: 32143659 [TBL] [Abstract][Full Text] [Related]